A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease.

Source:http://linkedlifedata.com/resource/pubmed/id/9928724

J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1999 Jan 1 20 1 11-9

Download in:

View as

General Info

PMID
9928724